These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 32395497)
1. Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma. Wang F; Tang C; Gao X; Xu J Ann Transl Med; 2020 Apr; 8(7):453. PubMed ID: 32395497 [TBL] [Abstract][Full Text] [Related]
2. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
3. Identification of a pyroptosis-related prognostic signature in breast cancer. Chen H; Luo H; Wang J; Li J; Jiang Y BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644 [TBL] [Abstract][Full Text] [Related]
4. A six-gene signature related with tumor mutation burden for predicting lymph node metastasis in breast cancer. Wang C; Xu K; Deng F; Liu Y; Huang J; Wang R; Guan X Transl Cancer Res; 2021 May; 10(5):2229-2246. PubMed ID: 35116541 [TBL] [Abstract][Full Text] [Related]
5. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients. Yan D; Chen Y Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270 [TBL] [Abstract][Full Text] [Related]
6. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
8. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer. Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y Front Oncol; 2021; 11():686044. PubMed ID: 34422642 [TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis. Wu Z; Wan J; Wang J; Meng X; Qian H Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509 [TBL] [Abstract][Full Text] [Related]
10. Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer. Ren X; Cui H; Wu J; Zhou R; Wang N; Liu D; Xie X; Zhang H; Liu D; Ma X; Dang C; Kang H; Lin S Cancer Med; 2022 Oct; 11(20):3886-3901. PubMed ID: 35441810 [TBL] [Abstract][Full Text] [Related]
11. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes. Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027 [TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module. Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152 [TBL] [Abstract][Full Text] [Related]
13. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer. Li X; Fu S; Huang Y; Luan T; Wang H; Wang J BMC Cancer; 2021 Nov; 21(1):1267. PubMed ID: 34819038 [TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. Yue C; Ma H; Zhou Y PeerJ; 2019; 7():e8128. PubMed ID: 31803536 [TBL] [Abstract][Full Text] [Related]
16. A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer. Zhang Z; Fang T; Lv Y Front Genet; 2022; 13():934830. PubMed ID: 36171887 [No Abstract] [Full Text] [Related]
17. The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer. Chen Q; Jun H; Yang C; Yang F; Xu Y J Oncol; 2022; 2022():3625790. PubMed ID: 36059808 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer. He M; Hu C; Deng J; Ji H; Tian W World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer. Yu J; Liu TT; Liang LL; Liu J; Cai HQ; Zeng J; Wang TT; Li J; Xiu L; Li N; Wu LY Cancer Cell Int; 2021 Jul; 21(1):353. PubMed ID: 34229669 [TBL] [Abstract][Full Text] [Related]
20. Identification and verification of immune-related gene prognostic signature based on ssGSEA for breast cancer. Chen G; Cao J; Zhao H; Cong Y; Qiao G Cent Eur J Immunol; 2022; 47(2):139-150. PubMed ID: 36751391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]